Erin Foran Wolff

Celmatix has appointed Erin Foran Wolff as its first chief medical officer. She will play an important role as the company prepares to launch its first genetic test and continues to scale its analytics platform, Polaris, already in use at leading fertility clinics across the US. Wolff comes to Celmatix from the National Institutes of Health, where she worked as an assistant clinical investigator and conducted basic, translational, and clinical reproductive research.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.